Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-interventional Study Evaluating Efficacy and Tolerance on TEAM Conditioning (Thiotepa/Etoposide/Aracytin/Melphalan) Followed by Autologous Haematopoietic Stem Cells Transplantation in Patients With Lymphoma

NCT02504190 is registered in ClinicalTrials.gov with Association for Training, Education, and Research in Hematology, Immunology, and Transplantation as lead sponsor.

NCT NCT02504190
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02504190 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-interventional Study Evaluating Efficacy and Tolerance on TEAM Conditioning (Thiotepa/Etoposide/Aracytin/Melphalan) Followed by Autologous Haematopoietic Stem Cells Transplantation in Patients With Lymphoma
Lead sponsor
Association for Training, Education, and Research in Hematology, Immunology, and Transplantation
Phase
Observational
Overall status
Completed
Start date
July 16, 2015
Completion date
November 30, 2019
Enrollment
95 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma